The airway mucosa responds to inflammatory provocations with bulk exud
ation of plasma into the airway tissue (vascular exudation) and lumen
(mucosal exudation). The intensity and time course of the exudative re
sponse can be relevantly examined by sampling and analysing airway sur
face liquids, because the luminal entry of plasma proteins/tracers pro
mptly and quantitatively reflects the exudative response of the airway
s. The process of mucosal exudation of plasma is a prominent feature o
f airway inflammation and has been demonstrated in rhinitis, asthma, a
nd bronchitis. Inflammatory mediators and allergen produce mucosal exu
dation of plasma into the airway lumen (outward permeability) whereas
the solute absorption across the mucosa (inward permeability) is unaff
ected. Hence, in contrast to current views, we have demonstrated that
in airway inflammation the solute absorption across the airway mucosa
is not increased. The findings suggest the plasma exudation response a
lso as a first line respiratory mucosal defence, allowing potent plasm
a protein systems to appear on an airway mucosa functionally intact as
a barrier toward undue luminal material. Our data on plasma exudation
and solute absorption across the mucosa of upper and lower airways fu
rther suggest the human nasal airways as a model relevant also for the
tracheobronchial airways.